Macroeconomic and Fiscal Effects of Increased Efficiency in Medicine Procurement: A General Equilibrium Analysis of the Colombian Health System
dc.audience | Policymakers | eng |
dc.audience | Researchers | eng |
dc.audience | Students | eng |
dc.audience | Teachers | eng |
dc.coverage.sucursal | Bogotá | spa |
dc.creator | Ávila-Montealegre, Oscar | spa |
dc.creator | Bauhoff, Sebastian | spa |
dc.creator | Botero-García, Jesús | spa |
dc.creator | Giles Álvarez, Laura | spa |
dc.creator | León-Moncada, Santiago | spa |
dc.creator | Larrahondo, Cristhian | spa |
dc.creator | Lozano-Espitia, Luis | spa |
dc.creator | Melo-Becerra, Ligia Alba | spa |
dc.creator | Ortiz-Hoyos, José Luis | spa |
dc.creator | Rodríguez-Ávila, Jesús | spa |
dc.creator.firma | Oscar, Ávila-Montealegre, | spa |
dc.creator.firma | Sebastian, Bauhoff | spa |
dc.creator.firma | Jesús, Botero-García | spa |
dc.creator.firma | Laura, Giles Álvarez | spa |
dc.creator.firma | Santiago, León-Moncada | spa |
dc.creator.firma | Cristhian, Larrahondo | spa |
dc.creator.firma | Luis, Lozano-Espitia | spa |
dc.creator.firma | Ligia Alba, Melo-Becerra | spa |
dc.creator.firma | José Luis, Ortiz-Hoyos | spa |
dc.creator.firma | Jesús, Rodríguez-Ávila | spa |
dc.date.accessioned | 2025-01-09T19:42:30Z | spa |
dc.date.available | 2025-01-09T19:42:30Z | spa |
dc.date.created | 2024-12 | spa |
dc.description | Este estudio analiza los efectos macroeconómicos y fiscales de una mayor eficiencia en la compra de medicamentos en Colombia. A este efecto, se utilizan modelos de equilibrio general, tanto en su versión estática (computable) como dinámica. Los resultados sugieren que la adopción de una política de compra eficiente de medicamentos podría reducir los gastos totales del sistema de salud, generando un ahorro de hasta el 8,4% en el corto plazo y hasta el 10,8% en el largo plazo. Dicho ahorro podría ser reinvertido en el propio sistema de salud, en otros sectores, o verse reflejado en una reducción de la carga tributaria sobre el capital, el consumo o las contribuciones sociales. Esta última opción incrementaría en hasta un 1,1% la producción, 1,7% la inversión y 0,8% el consumo. Son medidas clave para mejorar dicha eficiencia la promoción y adquisición de medicamentos genéricos, las compras conjuntas de medicamentos y la regulación de precios. | spa |
dc.description.abstract | This study analyzes the macroeconomic and fiscal effects of greater efficiency in medicines procurement in Colombia, using both static (computable) and dynamic general equilibrium models. The findings indicate that implementing an efficient drug procurement policy could reduce the total health system spending, with potential savings of up to 8.4% in the short term and up to 10.8% in the long term. These savings could be reinvested within the health system, allocated to other sectors, or used to reduce tax burden on capital, consumption, or social contributions. The latter option would increase production by up to 1.1%, investment by 1.7% and consumption by 0.8%. Potential measures to achieve such efficiency gains include promoting and purchasing generic drugs, conducting joint procurement, and implementing price regulation. | eng |
dc.format.extent | 32 páginas | spa |
dc.format.mimetype | spa | |
dc.identifier.handle | http://hdl.handle.net/20.500.12134/11075 | spa |
dc.identifier.uri | https://repositorio.banrep.gov.co/handle/20.500.12134/11075 | spa |
dc.language.iso | eng | eng |
dc.publisher | Banco Interamericado de Desarrollo - Banco de la República -- Universidad EAFIT | spa |
dc.relation.doi | http://dx.doi.org/10.18235/0013308 | spa |
dc.relation.ispartof | Documentos de Trabajo | spa |
dc.relation.uri | https://publications.iadb.org/es/efectos-macroeconomicos-y-fiscales-de-una-mayor-eficiencia-en-la-compra-de-medicamentos-un-analisis | spa |
dc.relation.uri | https://publications.iadb.org/en/macroeconomic-and-fiscal-effects-increased-efficiency-medicine-procurement-general-equilibrium | eng |
dc.rights.accessRights | Open Access | eng |
dc.rights.cc | Atribución 3.0 IGO CC BY 3.0 OIG | spa |
dc.rights.disclaimer | Las opiniones contenidas en el presente documento son responsabilidad exclusiva de los autores y no comprometen al Banco de la República ni a su Junta Directiva. | spa |
dc.rights.disclaimer | The opinions contained in this document are the sole responsibility of the author and do not commit Banco de la República or its Board of Directors. | eng |
dc.rights.spa | Acceso abierto | spa |
dc.rights.uri | https://creativecommons.org/licenses/by/3.0/igo/ | eng |
dc.subject | Medicamentos | spa |
dc.subject | Gasto en salud | spa |
dc.subject | Sistema de salud | spa |
dc.subject | Colombia | spa |
dc.subject | Impuestos | spa |
dc.subject | Modelos de equilibrio general | spa |
dc.subject | Política farmacéutica | spa |
dc.subject.brtema | 9. Sector público y temas sociales | spa |
dc.subject.jel | C68 - Computable General Equilibrium Models | eng |
dc.subject.jel | D58 - Computable and Other Applied General Equilibrium Models | eng |
dc.subject.jel | E62 - Fiscal Policy | eng |
dc.subject.jel | H21 - Efficiency; Optimal Taxation | eng |
dc.subject.jel | H51 - Government Expenditures and Health | eng |
dc.subject.jel | I11 - Analysis of Health Care Markets | eng |
dc.subject.jel | I18 - Government Policy; Regulation; Public Health | eng |
dc.subject.jelspa | D58 - Modelos computables y otros modelos aplicados de equilibrio general | spa |
dc.subject.jelspa | E62 - Política fiscal | spa |
dc.subject.jelspa | H21 - Eficiencia; Imposición óptima | spa |
dc.subject.jelspa | H51 - Gasto público de la administración y sanidad | spa |
dc.subject.jelspa | I11 - Análisis de los mercados de asistencia sanitaria | spa |
dc.subject.jelspa | I18 - Política pública; Regulación; Sanidad pública | spa |
dc.subject.keyword | Medications | eng |
dc.subject.keyword | Health expenditure | eng |
dc.subject.keyword | Health system | eng |
dc.subject.keyword | Colombia | eng |
dc.subject.keyword | Taxes | eng |
dc.subject.keyword | General equilibrium models | eng |
dc.subject.keyword | Pharmaceutical policy | eng |
dc.subject.lemb | Medicamentos -- Precios -- Colombia | spa |
dc.subject.lemb | Medicamentos genéricos --Aspectos económicos -- Colombia | spa |
dc.title | Macroeconomic and Fiscal Effects of Increased Efficiency in Medicine Procurement: A General Equilibrium Analysis of the Colombian Health System | eng |
dc.title.alternative | Efectos macroeconómicos y fiscales de una mayor eficiencia en la compra de medicamentos: un análisis de equilibrio general para el sistema de salud colombiano | spa |
dc.type | Working Paper | eng |
dc.type.hasversion | Published Version | eng |
dc.type.spa | Documentos de Trabajo | spa |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- Macroeconomic-and-Fiscal-Effects-of-Increased-Efficiency-in-Medicine-Procurement-A-General-Equilibrium-Analysis-of-the-Colombian-Health-System.pdf
- Size:
- 11.01 MB
- Format:
- Adobe Portable Document Format
- FILE
- https://repositorio.banrep.gov.co/bitstream/handle/20.500.12134/11075/Macroeconomic-and-Fiscal-Effects-of-Increased-Efficiency-in-Medicine-Procurement-A-General-Equilibrium-Analysis-of-the-Colombian-Health-System.pdf
- Description:
- Macroeconomic and Fiscal Effects of Increased Efficiency in Medicine Procurement: A General Equilibrium Analysis of the Colombian Health System
Loading...
- Name:
- Efectos-macroeconomicos-y-fiscales-de-una-mayor-eficiencia-en-la-compra-de-medicamentos.pdf
- Size:
- 10.97 MB
- Format:
- Adobe Portable Document Format
- FILE
- https://repositorio.banrep.gov.co/bitstream/handle/20.500.12134/11075/Efectos-macroeconomicos-y-fiscales-de-una-mayor-eficiencia-en-la-compra-de-medicamentos.pdf
- Description:
- Efectos macroeconomicos y fiscales de una mayor eficiencia en la compra de medicamentos
License bundle
1 - 1 of 1
- Name:
- license.txt
- Size:
- 5.3 KB
- Format:
- Item-specific license agreed upon to submission
- Description: